Device-detected AF, commonly labelled atrial high-rate episodes or subclinical AF (SCAF), creates a dilemma over anticoagulation: absolute stroke risk will be lowered, yet oral anticoagulation (OAC) carries a real risk of major bleeding. The author argues that... ...

请注册登录后继续浏览